ParkinsonCanadaV1, Main, Exploration, bibRecord, 002B17

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Identifieur interne : 002B17 ( Main/Exploration ); précédent : 002B16; suivant : 002B18

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Auteurs : Guy Chouinard [Canada] ; Howard C. Margolese [Canada]

Source :

Schizophrenia research [ 0920-9964 ] ; 2005.

RBID : Pascal:05-0294043

Descripteurs français

Pascal (Inist)
- Extrapyramidal syndrome, Psychométrie, Parkinsonisme, Dyskinésie, Tardif, Dystonie, Neuroleptique, Chimiothérapie, Traitement, Psychotrope, Antipsychotique, Schizophrénie, Echelle d'évaluation, Toxicité, Validation test, Fidélité test, Homme, Contrôle moteur.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Antipsychotic, Basal Ganglia Diseases (diagnosis), Basal Ganglia Diseases (epidemiology), Chemotherapy, Dyskinesia, Dystonia, Evaluation scale, Extrapyramidal syndrome, Facial Expression, Factor Analysis, Statistical, Gait, Human, Humans, Hypokinesia (epidemiology), Late, Manuals as Topic, Motor control, Muscle Rigidity (epidemiology), Neuroleptic, Parkinsonism, Posture, Psychometrics, Psychotropic, Schizophrenia, Severity of Illness Index, Speech, Surveys and Questionnaires, Test reliability, Test validation, Toxicity, Treatment, Tremor (epidemiology), Verbal Behavior.
MESH :
- diagnosis : Basal Ganglia Diseases.
- epidemiology : Basal Ganglia Diseases, Hypokinesia, Muscle Rigidity, Tremor.
- Facial Expression, Factor Analysis, Statistical, Gait, Humans, Manuals as Topic, Posture, Severity of Illness Index, Speech, Surveys and Questionnaires, Verbal Behavior.

Abstract

The Extrapyramidal Symptom Rating Scale (ESRS) was developed to assess four types of drug-induced movement disorders (DIMD): Parkinsonism, akathisia, dystonia, and tardive dyskinesia (TD). Comprehensive ESRS definitions and basic instructions are given. Factor analysis provided six ESRS factors: 1) hypokinetic Parkinsonism; 2) orofacial dyskinesia; 3) trunk/limb dyskinesia; 4) akathisia; 5) tremor; and 6) tardive dystonia. Two pivotal studies found high inter-rater reliability correlations in both antipsychotic-induced movement disorders and idiopathic Parkinson disease. For inter-rater reliability and certification of raters, ≥ 80% of item ratings of the complete scale should be ± 1 point of expert ratings and > 70% of ratings on individual items of each ESRS subscale should be ± 1 point of expert ratings. During a cross-scale comparison, AIMS and ESRS were found to have a 96% (359/374) agreement between TD-defined cases by DSM-IV TD criteria. Two recent international studies using the ESRS included over 3000 patients worldwide and showed an incidence of TD ranging from 10.2% (2000) to 12% (1998). ESRS specificity was investigated through two different approaches, path analyses and ANCOVA PANSS factors changes, which found that ESRS measurement of drug-induced EPS is valid and discriminative from psychiatric symptoms.

Affiliations:

Canada

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Manual for the Extrapyramidal Symptom Rating Scale (ESRS)</title>
<author><name sortKey="Chouinard, Guy" sort="Chouinard, Guy" uniqKey="Chouinard G" first="Guy" last="Chouinard">Guy Chouinard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, 1025 Pine Ave. West</s1>
<s2>Montreal, QC, H3A 1A1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC, H3A 1A1</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Fernand-Seguin Research Centre, Louis-H. Lafontaine Hospital, Montreal and Department of Psychiatry University of Montreal</s1>
<s2>Montreal, QC, H1N 3M5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC, H1N 3M5</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Margolese, Howard C" sort="Margolese, Howard C" uniqKey="Margolese H" first="Howard C." last="Margolese">Howard C. Margolese</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, 1025 Pine Ave. West</s1>
<s2>Montreal, QC, H3A 1A1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC, H3A 1A1</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0294043</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0294043 INIST</idno>
<idno type="RBID">Pascal:05-0294043</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000907</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000416</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000785</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000785</idno>
<idno type="wicri:doubleKey">0920-9964:2005:Chouinard G:manual:for:the</idno>
<idno type="wicri:Area/Main/Merge">002E53</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15949657</idno>
<idno type="wicri:Area/PubMed/Corpus">001249</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001249</idno>
<idno type="wicri:Area/PubMed/Curation">001249</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001249</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001249</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001249</idno>
<idno type="wicri:Area/Ncbi/Merge">000547</idno>
<idno type="wicri:Area/Ncbi/Curation">000547</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000547</idno>
<idno type="wicri:doubleKey">0920-9964:2005:Chouinard G:manual:for:the</idno>
<idno type="wicri:Area/Main/Merge">002C93</idno>
<idno type="wicri:Area/Main/Curation">002B17</idno>
<idno type="wicri:Area/Main/Exploration">002B17</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Manual for the Extrapyramidal Symptom Rating Scale (ESRS)</title>
<author><name sortKey="Chouinard, Guy" sort="Chouinard, Guy" uniqKey="Chouinard G" first="Guy" last="Chouinard">Guy Chouinard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, 1025 Pine Ave. West</s1>
<s2>Montreal, QC, H3A 1A1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC, H3A 1A1</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Fernand-Seguin Research Centre, Louis-H. Lafontaine Hospital, Montreal and Department of Psychiatry University of Montreal</s1>
<s2>Montreal, QC, H1N 3M5</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC, H1N 3M5</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Margolese, Howard C" sort="Margolese, Howard C" uniqKey="Margolese H" first="Howard C." last="Margolese">Howard C. Margolese</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Clinical Psychopharmacology Unit, Allan Memorial Institute, McGill University Health Centre, and Department of Psychiatry, McGill University, 1025 Pine Ave. West</s1>
<s2>Montreal, QC, H3A 1A1</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Montreal, QC, H3A 1A1</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Schizophrenia research</title>
<title level="j" type="abbreviated">Schizophr. res.</title>
<idno type="ISSN">0920-9964</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Schizophrenia research</title>
<title level="j" type="abbreviated">Schizophr. res.</title>
<idno type="ISSN">0920-9964</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic</term>
<term>Basal Ganglia Diseases (diagnosis)</term>
<term>Basal Ganglia Diseases (epidemiology)</term>
<term>Chemotherapy</term>
<term>Dyskinesia</term>
<term>Dystonia</term>
<term>Evaluation scale</term>
<term>Extrapyramidal syndrome</term>
<term>Facial Expression</term>
<term>Factor Analysis, Statistical</term>
<term>Gait</term>
<term>Human</term>
<term>Humans</term>
<term>Hypokinesia (epidemiology)</term>
<term>Late</term>
<term>Manuals as Topic</term>
<term>Motor control</term>
<term>Muscle Rigidity (epidemiology)</term>
<term>Neuroleptic</term>
<term>Parkinsonism</term>
<term>Posture</term>
<term>Psychometrics</term>
<term>Psychotropic</term>
<term>Schizophrenia</term>
<term>Severity of Illness Index</term>
<term>Speech</term>
<term>Surveys and Questionnaires</term>
<term>Test reliability</term>
<term>Test validation</term>
<term>Toxicity</term>
<term>Treatment</term>
<term>Tremor (epidemiology)</term>
<term>Verbal Behavior</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Basal Ganglia Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Basal Ganglia Diseases</term>
<term>Hypokinesia</term>
<term>Muscle Rigidity</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Facial Expression</term>
<term>Factor Analysis, Statistical</term>
<term>Gait</term>
<term>Humans</term>
<term>Manuals as Topic</term>
<term>Posture</term>
<term>Severity of Illness Index</term>
<term>Speech</term>
<term>Surveys and Questionnaires</term>
<term>Verbal Behavior</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Extrapyramidal syndrome</term>
<term>Psychométrie</term>
<term>Parkinsonisme</term>
<term>Dyskinésie</term>
<term>Tardif</term>
<term>Dystonie</term>
<term>Neuroleptique</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Psychotrope</term>
<term>Antipsychotique</term>
<term>Schizophrénie</term>
<term>Echelle d'évaluation</term>
<term>Toxicité</term>
<term>Validation test</term>
<term>Fidélité test</term>
<term>Homme</term>
<term>Contrôle moteur</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The Extrapyramidal Symptom Rating Scale (ESRS) was developed to assess four types of drug-induced movement disorders (DIMD): Parkinsonism, akathisia, dystonia, and tardive dyskinesia (TD). Comprehensive ESRS definitions and basic instructions are given. Factor analysis provided six ESRS factors: 1) hypokinetic Parkinsonism; 2) orofacial dyskinesia; 3) trunk/limb dyskinesia; 4) akathisia; 5) tremor; and 6) tardive dystonia. Two pivotal studies found high inter-rater reliability correlations in both antipsychotic-induced movement disorders and idiopathic Parkinson disease. For inter-rater reliability and certification of raters, ≥ 80% of item ratings of the complete scale should be ± 1 point of expert ratings and > 70% of ratings on individual items of each ESRS subscale should be ± 1 point of expert ratings. During a cross-scale comparison, AIMS and ESRS were found to have a 96% (359/374) agreement between TD-defined cases by DSM-IV TD criteria. Two recent international studies using the ESRS included over 3000 patients worldwide and showed an incidence of TD ranging from 10.2% (2000) to 12% (1998). ESRS specificity was investigated through two different approaches, path analyses and ANCOVA PANSS factors changes, which found that ESRS measurement of drug-induced EPS is valid and discriminative from psychiatric symptoms.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Chouinard, Guy" sort="Chouinard, Guy" uniqKey="Chouinard G" first="Guy" last="Chouinard">Guy Chouinard</name>
</noRegion>
<name sortKey="Chouinard, Guy" sort="Chouinard, Guy" uniqKey="Chouinard G" first="Guy" last="Chouinard">Guy Chouinard</name>
<name sortKey="Margolese, Howard C" sort="Margolese, Howard C" uniqKey="Margolese H" first="Howard C." last="Margolese">Howard C. Margolese</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B17 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B17 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:05-0294043
   |texte=   Manual for the Extrapyramidal Symptom Rating Scale (ESRS)
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.